Clinical trial
Effect of Long Term Trimetazidine Treatment on Myocardial Final Fibrosis for Acute Myocardial Infarction
NCT07325955 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Long Term Trimetazidine Treatment on Myocardial Final Fibrosis for Acute Myocardial Infarction
- Lead sponsor
- Chinese PLA General Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2020
- Completion date
- December 1, 2024
- Enrollment
- 194 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
st elevation myocardial infarction (stemi)